dna Communications

Niamh Mangan

dna Communications has appointed Niamh Mangan as executive vice president and managing director. Mangan brings 14 years of experience in global medical communications to her new position. She joins from 90TEN, where she most recently held the position of managing director. Earlier in her career, she held several roles at Cello Health Cypher.

RevHealth

Marcia Goddard

RevHealth has appointed Marcia Goddard as chief creative officer. Goddard brings a decade of experience in leadership positions to the role. She most recently served as chief creative officer at Fishawack Health. Goddard previously served as president at McCann Health New Jersey and, prior to this, as executive vice president and chief creative officer.

Vynamic

Gemma Pfister

Vynamic has appointed Gemma Pfister as head of life sciences, Europe. Pfister holds over two decades of experience specialising in pharmaceuticals and biotechnology. She most recently served as senior executive and London hub lead at Vynamic. Earlier in her career, Pfister served as senior vice president at InterPhase Consult and Gardiner-Caldwell Communications.

Current Global

Stephanie Shelton

Current Global has appointed Stephanie Shelton as executive vice president of client experience. Shelton brings a wealth of experience of traditional healthcare, corporate health and consumer health experience to her new position. She most recently served as senior vice president and senior partner at FleishmanHillard. Prior to this, she served as group managing director at W2O Group.

RevHealth

Deb Jamer

RevHealth has appointed Deb Jamer as chief operations officer. Jamer has over two decades of experience in leading agency growth. She most recently freelanced as an organisational development and operations consultant. Prior to this, Jamer served as senior vice president of operations at McCann Health New Jersey and later as executive vice president of operations.

BOLDSCIENCE

Kristin Ludwig

BOLDSCIENCE has appointed Kristin Ludwig as senior vice president of BOLDADVOCACY. Ludwig has over three decades of experience in areas including medical PR and patient advocacy. She most recently served as vice president, global corporate communications and patient affairs at EQRx. Prior to this, Ludwig held multiple roles at the American Society of Clinical Oncology.

The Considered

Chelsea McCloskey-Lambert

The Considered has appointed Chelsea McCloskey-Lambert as vice president medical director. McCloskey-Lambert holds a wealth of experience in the pharmaceutical marketing and communication industry. She most recently served as scientific director at Real Chemistry. Prior to this, McCloskey-Lambert served as scientific director at Sciris and Pulsar Health earlier in her career.

The Considered

Vini Watson

The Considered has appointed Vini Watson as vice president studio director. Watson brings nearly three decades of graphic design and creative innovation to his new role. He most recently served as design consultant at the company. Prior to The Considered, Watson served as global innovation director at Envision Pharma Group.